Cognitive decline is multi-factorial but rarely treated as such due to clinical complexity of the process. Emerging data driven systems with assistive-AI enable physicians to deliver comprehensive and personalized care at scale. Vik's session introduces uMETHOD's RestoreU solution, a software based service which is helping transform care of cognitive decline and its costs to society. The solution is available nationwide through several diagnostic lab service providers. To view Vik's discussion…READ MORE

As a part of its efforts during Alzheimer's Awareness Month, uMETHOD is educating the public on the risk factors associated with Alzheimer's and the importance of early intervention. Alzheimer's disease is a progressive brain disorder that affects 5.7 million U.S. adults, with many more in preceding stages of decline. The impacts of the disease are devastating and extend beyond memory loss. Alzheimer's and dementia can bring pain, stress, financial ruin,…READ MORE

OKLAHOMA CITY, Oct. 17, 2023 -- Tribal Diagnostics, a high-complexity diagnostics laboratory, has announced availability of the RestoreU™ Dementia Panel throughout Texas and Oklahoma. RestoreU is a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. RestoreU's Assistive AI improves care for individuals suffering from chronic diseases like Alzheimer's with multiple underlying medical causes. It creates…READ MORE

…READ MORE

Alzheimer’s is a disease of data. The disease doesn’t have what we typically react to quickly: There is no pain, no blood, no pus, no rash, no dry mouth, nothing is visibly out of kilter.  Yet, Alzheimer’s disease generally starts its destruction 20 years before symptoms (most notably memory loss) are acknowledged. There can be more than 50 treatable causes to be dealt with simultaneously. More than half of the…READ MORE

Raleigh-based uMethod was founded in 2013 to help doctors treat patients suffering from cognitive problems like dementia and Alzheimer’s. The SaaS platform provides a service to doctors, who order blood tests for a patient suffering from cognitive decline in order to create a personalized AI-generated care plan.  AI collects data on patients from blood tests ordered by their doctor and devises a treatment plan by analyzing treatable causes such as infection, inflammation,…READ MORE

RESEARCH TRIANGLE PARK –  Alzheimer’s Disease and dementia have long been feared by many, especially those with first-hand experience. Vik Chandra, CEO and co-founder of uMETHOD is familiar with this disease having seen it in both his grandmother and mother-in-law. According to Chandra, there are 17 and a half million Medicare-aged patients somewhere on a spectrum of cognitive decline, and about 150,000 doctors across the country caring for these patients. He is passionate…READ MORE

Quest Diagnostics unveiled a new artificial intelligence-based test service in the U.S. that aims to help physicians improve the detection of dementia and create better outcomes for patients. Through a partnership with Raleigh, N.C.-based health technology company uMETHOD Health, the Secaucus-headquartered testing provider added the RestoreU Dementia Panel to its testing portfolio, according to a May 4 announcement. Dr. Michael Racke, Quest’s neurology medical director, said, “With so much attention on emerging therapies for…READ MORE

More than six million Americans are living with Alzheimer’s disease — and one in three seniors dies with the disease, according to statistics from the Alzheimer’s Association. With so many different factors — genetics, lifestyle and environment — influencing a person’s risk of developing Alzheimer’s, many doctors are moving away from one-size-fits-all approaches and calling for more individualized treatments. It’s a concept known as precision medicine. And it’s what inspired a…READ MORE

Secaucus, NJ and Raleigh, NC – May 4, 2023 – Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced nationwide availability of the RestoreU™ Dementia Panel, a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. The RestoreU service employs artificial intelligence…READ MORE